Episode 32 - Neurotransmitters

Episode 32 • March 23, 2023 • 00:28:55
Episode 32 - Neurotransmitters
The Chronic Fatigue and Burnout Recovery Podcast
Episode 32 - Neurotransmitters

Mar 23 2023 | 00:28:55

/

Hosted By

Anna Marsh

Show Notes

Shownotes

Anna shares her perspective on addressing the imbalance of neurotransmitters in fatigue recovery. She zooms out and offers an understanding about how taking a big-picture view can be much more successful and beneficial in the long term.

Products Mentioned (you can use the code AMARSH10 for 10% off)*

Sleep Supplement for Gaba Support:

https://naturaldispensary.co.uk/products/Sleep_150g-10005169-0.html

L-theanine and Lemon Balm:

https://naturaldispensary.co.uk/products/L_Theanine_and_Lemon_Balm_90_s-13318-0.html

*people who experience Chronic and Complex health conditions can be sensitive to supplements. Sometimes supplements intended to make you feel better, can make you feel worse. It may be best to discuss any changes to your health care with your doctor or a trained professional who has an understanding of your case.

Useful links:

Website: http://annamarsh.co.uk/

Instagram: https://www.instagram.com/anna__marsh_

Work with me: https://annamarsh.co.uk/work-together/

Other Episodes

Episode 0

April 26, 2024 • 00:31:38
Episode Cover

Episode 81 - The ONE Thing You Must Master In Your Fatigue Recovery

Stability is the foundation of healing. As humans we are self-organising, self-healing human beings. Yet, in chronic illness the body has become increasingly disorganised...

Listen

Episode 53

September 14, 2023 • 00:49:03
Episode Cover

Episode 53 - Parasites and Chronic Fatigue

Shownotes If you have ever wondered if parasites could be impacting your health and energy, this episode is for you. This episode focuses on...

Listen

Episode 0

August 22, 2025 • 00:20:45
Episode Cover

Episode 131: GLP-1  Receptor Agonists, MCAS and Chronic Fatigue

Glucagon-Like-Peptide-1 receptor agonists (GLP-1 RA) are a class of medications originally developed to treat type 2 diabetes, but have since gained widespread attention for...

Listen